Alivus Life Sciences: Board Meeting Outcome for Unaudited Financial Results For The Third Quarter And Nine Months Ended December 31 2025.

Pursuant to Regulations 30 and 33 of the SEBI (LODR) 2015 we wish to inform you that the Board at its meeting held today approved the unaudited Financial Results for the Third Quarter and Nine Months ended December 31 2025.